Level Four Advisory Services’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Level Four Advisory Services's VKTX Position: Q2 2025 in Review
Level Four Advisory Services sold out of Viking Therapeutics (VKTX) in Q2 2025, closing a stake of 8,327 shares — an estimated $201K sold.
Level Four Advisory Services first reported a position in VKTX in Q1 2023 and held it in 9 quarters. The position peaked at $826K in Q2 2023. 392 funds tracked by Wall St. Rank hold VKTX as of Q2 2025.
- Level Four Advisory Services reported no remaining Viking Therapeutics position as of Q2 2025 after selling out during the quarter.
- Level Four Advisory Services sold 8,327 Viking Therapeutics shares in Q2 2025, an estimated $201K.
- Level Four Advisory Services first reported a position in Viking Therapeutics in Q1 2023 and held it in 9 quarters.
- Level Four Advisory Services's Viking Therapeutics position peaked at $826K in Q2 2023.
- 392 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2025.
Based on Level Four Advisory Services's 13F filing for Q2 2025, filed 13 Aug 2025.